Literature DB >> 19854161

Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes.

Nadine Schmidt1, Andrea Pautz, Julia Art, Peter Rauschkolb, Matthias Jung, Gerhard Erkel, Mary B Goldring, Hartmut Kleinert.   

Abstract

Chondrocytes are important for the development and maintenance of articular cartilage. However, both in osteoarthritis (OA) and rheumatoid arthritis (RA) chondrocytes are involved in the process of cartilage degradation and synthesize important immunomodulatory mediators, including nitric oxide (NO) generated by the inducible NO synthase (iNOS). To uncover the role of iNOS in the pathomechanisms of OA and RA, we analyzed the regulation of iNOS expression using immortalized human chondrocytes as a reproducible model. In C-28/I2 chondrocytes, iNOS expression was associated with the expression of the chondrocyte phenotype. Peak induction by a cytokine cocktail occurred between 6 and 8h and declined by 24h. Inhibition of p38MAPK, NF-kappaB and the JAK2-STAT-1alpha pathways resulted in a reduction of iNOS expression. In contrast to other cell types, the cytokine-mediated induction of the human iNOS promoter paralleled the induction rate of the iNOS mRNA expression in C-28/I2 chondrocytes. However, in addition post-transcriptional regulation of iNOS expression by the RNA binding protein KSRP seems to operate in these cells. As seen in other chondrocyte models, glucocorticoids were not able to inhibit cytokine-induced iNOS expression in C-28/I2 cells, due to the lack of the glucocorticoid receptor mRNA expression. In this model of glucocorticoid-resistance, the new fungal anti-inflammatory compound S-curvularin was able to inhibit cytokine-induced iNOS expression and iNOS-dependent NO-production. In summary, we demonstrate for the first time that differentiated human immortalized C-28/I2 chondrocytes are a representative cell culture model to investigate iNOS gene expression in human joint diseases. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854161      PMCID: PMC3951130          DOI: 10.1016/j.bcp.2009.10.012

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  50 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38.

Authors:  Andrew R Clark; Jonathan L E Dean; Jeremy Saklatvala
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

3.  Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B.

Authors:  R W Ganster; B S Taylor; L Shao; D A Geller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis.

Authors:  David G Stokes; Gang Liu; Ibsen B Coimbra; Sonsoles Piera-Velazquez; Robert M Crowl; Sergio A Jiménez
Journal:  Arthritis Rheum       Date:  2002-02

5.  Hypoxia-inducible factor 1 alpha upregulates the expression of inducible nitric oxide synthase gene in pulmonary arteries of hyposic rat.

Authors:  Ruicheng Hu; Aiguo Dai; Shuangxiang Tan
Journal:  Chin Med J (Engl)       Date:  2002-12       Impact factor: 2.628

6.  Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension.

Authors:  T Wallerath; K Witte; S C Schäfer; P M Schwarz; W Prellwitz; P Wohlfart; H Kleinert; H A Lehr; B Lemmer; U Förstermann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

7.  p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2.

Authors:  Narayan R Bhat; Douglas L Feinstein; Qin Shen; Aruna N Bhat
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

8.  Sporogen, S14-95, and S-curvularin, three inhibitors of human inducible nitric-oxide synthase expression isolated from fungi.

Authors:  Ying Yao; Michael Hausding; Gerhard Erkel; Timm Anke; Ulrich Förstermann; Hartmut Kleinert
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

9.  Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression.

Authors:  Andrea Witteck; Ying Yao; Marcel Fechir; Ulrich Förstermann; Hartmut Kleinert
Journal:  Exp Cell Res       Date:  2003-07-01       Impact factor: 3.905

10.  Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption.

Authors:  R J van't Hof; K J Armour; L M Smith; K E Armour; X Q Wei; F Y Liew; S H Ralston
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

View more
  21 in total

1.  Effects of perfusion and dynamic loading on human neocartilage formation in alginate hydrogels.

Authors:  Shawn P Grogan; Sujata Sovani; Chantal Pauli; Jianfen Chen; Andreas Hartmann; Clifford W Colwell; Martin K Lotz; Darryl D D'Lima
Journal:  Tissue Eng Part A       Date:  2012-06-12       Impact factor: 3.845

2.  Endothelial nitric oxide synthase inhibits the development of autoimmune-mediated vasculitis in mice.

Authors:  Trenton R Schoeb; Tambi Jarmi; M John Hicks; Scott Henke; Abolfazl Zarjou; Hitoshi Suzuki; Philip Kramer; Jan Novak; Anupam Agarwal; Daniel C Bullard
Journal:  Arthritis Rheum       Date:  2012-12

3.  Thioesterase domains of fungal nonreducing polyketide synthases act as decision gates during combinatorial biosynthesis.

Authors:  Yuquan Xu; Tong Zhou; Shuwei Zhang; Li-Jiang Xuan; Jixun Zhan; István Molnár
Journal:  J Am Chem Soc       Date:  2013-07-12       Impact factor: 15.419

4.  U0126, an Inhibitor of MEK1/2, Increases Tumor Necrosis Factor-α-Induced Apoptosis, but not Interleukin-6 Induced Apoptosis in C-28/I2 Human Chondrocytes.

Authors:  Charles J Malemud; Aaron C Lewis; Meredith A Wylie; Evan C Meszaros; Yelenna Skomorovska-Prokvolit; Sam Mesiano
Journal:  J Autoimmune Disord       Date:  2015-11-07

5.  SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.

Authors:  Priscilla S Redd; Mohammed L Ibrahim; John D Klement; Sarah K Sharman; Amy V Paschall; Dafeng Yang; Asha Nayak-Kapoor; Kebin Liu
Journal:  Cancer Res       Date:  2017-04-05       Impact factor: 12.701

6.  Characterization of the biosynthetic genes for 10,11-dehydrocurvularin, a heat shock response-modulating anticancer fungal polyketide from Aspergillus terreus.

Authors:  Yuquan Xu; Patricia Espinosa-Artiles; Vivien Schubert; Ya-ming Xu; Wei Zhang; Min Lin; A A Leslie Gunatilaka; Roderich Süssmuth; István Molnár
Journal:  Appl Environ Microbiol       Date:  2013-01-18       Impact factor: 4.792

7.  Endothelial dysfunction in tristetraprolin-deficient mice is not caused by enhanced tumor necrosis factor-α expression.

Authors:  Franziska Bollmann; Zhixiong Wu; Matthias Oelze; Daniel Siuda; Ning Xia; Jenny Henke; Andreas Daiber; Huige Li; Deborah J Stumpo; Perry J Blackshear; Hartmut Kleinert; Andrea Pautz
Journal:  J Biol Chem       Date:  2014-04-11       Impact factor: 5.157

8.  Rational reprogramming of fungal polyketide first-ring cyclization.

Authors:  Yuquan Xu; Tong Zhou; Zhengfu Zhou; Shiyou Su; Sue A Roberts; William R Montfort; Jia Zeng; Ming Chen; Wei Zhang; Min Lin; Jixun Zhan; István Molnár
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 9.  Role of KSRP in control of type I interferon and cytokine expression.

Authors:  Peter H King; Ching-Yi Chen
Journal:  J Interferon Cytokine Res       Date:  2014-04       Impact factor: 2.607

Review 10.  Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis.

Authors:  Manon C Zweers; Tineke N de Boer; Joël van Roon; Johannes W J Bijlsma; Floris P J G Lafeber; Simon C Mastbergen
Journal:  Arthritis Res Ther       Date:  2011-09-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.